Revive Therapeutics LtdOTCQB:RVVTFView on Canadian Exchange
- LAST PRICE0.0166
- TODAY'S CHANGE (%)-0.0010 (-5.6818%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0188 / 0.0176
- Day Range
- 52 Week Range
- Volume50,848
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | RVVTF |
|---|---|---|
| 09:56 ET | 22500 | 0.016 |
| 11:22 ET | 200 | 0.01775 |
| 12:02 ET | 1135 | 0.0177 |
| 12:18 ET | 1000 | 0.01765 |
| 01:37 ET | 2500 | 0.01746 |
| 01:39 ET | 5000 | 0.01675 |
| 02:51 ET | 13200 | 0.0166 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Revive Therapeutics Ltd | 10.4M | 0.0x | --- |
Company Information
Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics for rare disorders and infectious diseases. The Company is exploring the use of Bucillamine for the treatment of infectious diseases, with an initial focus on severe influenza and COVID-19. Through its subsidiary, Psilocin Pharma Corp., the Company is advancing the development of Psilocybin-based therapeutics in various diseases and disorders. The Company’s cannabinoid pharmaceutical portfolio focuses on rare inflammatory diseases and the Company was granted Food and Drug Administration (FDA) orphan drug status designation for the use of Cannabidiol (CBD) to treat autoimmune hepatitis (liver disease) and to treat ischemia and reperfusion injury from organ transplantation.
Contact Information
- Headquarters
- 82 Richmond Street EastTORONTO, ON, Canada M5C 1P1
- Phone
- 905-605-5535
- Fax
- 905-605-5535
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $10.4M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 418.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.31 |
EPS | $-0.01 |
Book Value | $0.03 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
